Evidence map›Paper›PMID 38836946›Full record

ReviewOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2024

Optimisation of vitamin D status in global populations.

N C Harvey, K A Ward, D Agnusdei, N Binkley, E Biver, C Campusano, E Cavalier, P Clark, M Diaz-Curiel, G E-H Fuleihan and 8 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Observational
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

N C HarveyMRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, SO16 6YD, UK. nch@mrc.soton.ac.uk.ORCID http://orcid.org/0000-0002-8194-2512
K A WardMRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, SO16 6YD, UK.ORCID https://orcid.org/0000-0001-7034-6750
D AgnusdeiUniversity of Siena, Siena, Italy.ORCID https://orcid.org/0000-0002-2502-475X
N BinkleyUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA.ORCID https://orcid.org/0000-0002-9905-461X
E BiverDivision of Bone Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0000-0001-6174-1951
C CampusanoInternal Medicine Department, Clínica Universidad de los Andes and Universidad de los Andes, Santiago, Chile.ORCID https://orcid.org/0000-0001-5483-9301
E CavalierDepartment of Clinical Chemistry, University of Liege, CIRM, CHU de Liège, Liège, Belgium.ORCID https://orcid.org/0000-0003-0947-2226
P ClarkClinical Epidemiology Unit, Hospital Infantil Federico Gómez-Facultad de Medicina UNAM, Mexico, Mexico.ORCID https://orcid.org/0000-0001-7981-5357
M Diaz-CurielFundacion Jimenez Diaz, Autonoma University, Madrid, Spain.ORCID https://orcid.org/0000-0002-7762-9398
G E-H FuleihanCalcium Metabolism and Osteoporosis Program, Division of Endocrinology, WHO Collaborating Center for Metabolic Bone Disorders, American University of Beirut, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-2076-5858
P KhashayarInternational Institute for Biosensing, University of Minnesota, Minneapolis, USA.ORCID https://orcid.org/0000-0001-7525-8418
N E LaneDivision of Rheumatology, Department of Medicine, U.C. Davis Health, Sacramento, CA, USA.ORCID https://orcid.org/0000-0002-0177-2198
O D MessinaIRO Medical Research Centre, Collaborating Centre WHO, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-7987-854X
A MithalInstitute of Endocrinology and Diabetes, Max Healthcare, Delhi, India.ORCID https://orcid.org/0000-0002-0822-3212
R RizzoliGeneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-1537-422X
C SemposVitamin D Standardization Program (VDSP), Havre de Grace, MD, USA.ORCID https://orcid.org/0000-0003-1324-3282
B Dawson-HughesJean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA.ORCID https://orcid.org/0000-0003-3136-0386
International Osteoporosis Foundation Vitamin D Working Group

Funding

Medical Research Council MC_PC_21003Medical Research Council MC_UP_A620_1015Medical Research Council MC_UU_12011/2
6 · The paper itself

Abstract

Vitamin D is important for musculoskeletal health. Concentrations of 25-hydroxyvitamin D, the most commonly measured metabolite, vary markedly around the world and are influenced by many factors including sun exposure, skin pigmentation, covering, season and supplement use. Whilst overt vitamin D deficiency with biochemical consequences presents an increased risk of severe sequelae such as rickets, osteomalacia or cardiomyopathy and usually warrants prompt replacement treatment, the role of vitamin D supplementation in the population presents a different set of considerations. Here the issue is to keep, on average, the population at a level whereby the risk of adverse health outcomes in the population is minimised. This position paper, which complements recently published work from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, addresses key considerations regarding vitamin D assessment and intervention from the population perspective. This position paper, on behalf of the International Osteoporosis Foundation Vitamin D Working Group, summarises the burden and possible amelioration of vitamin D deficiency in global populations. It addresses key issues including screening, supplementation and food fortification.

Indexed as

Dietary SupplementsGlobal HealthVitamin DVitamin D DeficiencyBone Density Conservation AgentsFood, FortifiedHumansMass Screening25-hydroxyvitamin DBone Density Conservation AgentsVitamin DCholecalciferolDeficiencyErgocalciferolPopulationSupplementationVitamin D

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.